Asacol and Protein - urine - a phase IV clinical study of FDA data

Summary:

Protein - urine is reported as a side effect among people who take Asacol (mesalamine), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Neurontin, and have Osteopenia.

The phase IV clinical study analyzes which people have Protein - urine when taking Asacol. It is created by eHealthMe based on reports of 19,898 people who have side effects when taking Asacol from the FDA, and is updated regularly.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 20,618 Asacol users. Check the latest studies of Asacol.

What is Protein - urine?

Protein - urine is found to be associated with 1,582 drugs and 2,011 conditions by eHealthMe. Check the latest studies of Protein - urine.

On Jul, 07, 2026

19,898 people reported to have side effects when taking Asacol.
Among them, 27 people (0.14%) have Protein - urine.

Among these 27 people:

How long have people been on Asacol when they have Protein - urine? *

What is the gender of people who have Protein - urine when taking Asacol? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Protein - urine when taking Asacol? *

What are other drugs people take besides Asacol? *

What are other side effects people have besides Protein - urine? *

High Blood Pressure: 19 people, 70.37%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 18 people, 66.67%
Haematuria (presence of blood in urine): 17 people, 62.96%
Diarrhea Haemorrhagic: 16 people, 59.26%
Diarrhea: 16 people, 59.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 15 people, 55.56%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 15 people, 55.56%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 15 people, 55.56%
Intestinal Obstruction: 15 people, 55.56%
Intervertebral Disc Space Narrowing (spinal disc space narrowing): 15 people, 55.56%

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 15 people, 55.56%
Osteoporosis (bones weak and more likely to break): 3 people, 11.11%
Vitamin B12 Deficiency: 1 person, 3.70%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.70%
High Blood Pressure: 1 person, 3.70%
Hepatocellular Carcinoma (liver cancer): 1 person, 3.70%
Hepatic Neoplasm Malignant (liver cancer): 1 person, 3.70%
Furuncle (infection of the hair follicle): 1 person, 3.70%
Allergic Rhinitis: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Asacol and have Protein - urine?

- Check whether Protein - urine is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Asacol:

Asacol (20,618 reports)

Protein - urine treatments and more:

Protein - urine (24,757 reports)

Browse all side effects of Asacol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Protein - urine:

Protein - urine (1,582 drugs)

Browse all the conditions that are associated with Protein - urine:

Protein - urine (2,011 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Asacol) and Asacol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.